UCB 24/30 MTNUCB 24/30 MTNUCB 24/30 MTN

UCB 24/30 MTN

No trades
See on Supercharts

BE39011982 analysis



Key facts


Issuer
Issue date
Mar 20, 2024
Maturity date
Mar 20, 2030
Outstanding amount
‪500.00 M‬EUR
Face value
100,000.00EUR
Minimum denomination
100,000.00EUR
Coupon
4.25% (Fixed)
Yield to maturity
3.53%
UCB SA engages in the research and development of biopharmaceuticals products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.